Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novo-nordisk As

Start price
Target price
Perf. (%)
€110.02
06.02.24
-
06.02.25
22.76%
02.07.24

buy
Fastly Inc.

Start price
Target price
Perf. (%)
€20.10
06.02.24
-
06.02.25
-74.19%
09.08.24

buy
Uipath Inc.

Start price
Target price
Perf. (%)
€20.90
05.02.24
€30.00
05.02.25
8.61%
17.02.24

EBIT growth >5% per year expected
Top 10 in its market
Good rating
Standard Investments for future growth
buy
Affirm Hldgs Inc

Start price
Target price
Perf. (%)
€38.10
05.02.24
€50.00
05.02.25
-6.82%
17.02.24

EBIT growth >5% per year expected
Standard Investments for future growth
Some uniques
Revenue growth > 30% per year expected
buy
Li-ft Power Ltd.

Start price
Target price
Perf. (%)
€3.23
05.02.24
€10.00
05.02.25
-3.41%
17.02.24

Good rating
High Investments for future growth
Revenue growth > 30% per year expected
Sustainability is little important
buy
Neon Equity AG

Start price
Target price
Perf. (%)
€7.90
05.02.24
-
05.02.25
-80.13%
08.08.24

Ibio Inc.

Start price
Target price
Perf. (%)
€3.51
05.02.24
-
05.02.25
-
30.11.23

buy
Top Ships Inc.

Start price
Target price
Perf. (%)
€12.40
05.02.24
€26.00
05.02.25
1.61%
27.02.24

Could be very worthwhile Investment >20% year
Cantourage Group SE

Start price
Target price
Perf. (%)
€10.50
05.02.24
-
05.02.25
-16.29%
17.02.24

Risky Investment
Cannovum Cannabis AG

Start price
Target price
Perf. (%)
€3.44
05.02.24
-
05.02.25
-22.67%
17.02.24

Annovis Bio Inc.

Start price
Target price
Perf. (%)
€9.37
04.02.24
-
04.02.25
1.81%
18.02.24

buy
Clearmind Medicine Inc.

Start price
Target price
Perf. (%)
€1.65
04.02.24
€3.00
04.02.25
-26.06%
17.02.24

buy
Addex Therapeutics Sa

Start price
Target price
Perf. (%)
€9.00
04.02.24
€12.00
31.05.25
148.89%
15.04.24

Could be very worthwhile Investment >20% year
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€9.37
04.02.24
-
04.02.25
1.81%
17.02.24

Risky Investment
buy
Claranova S.a.

Start price
Target price
Perf. (%)
€2.23
03.02.24
-
03.02.25
-34.98%
08.08.24

buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€3.56
03.02.24
-
03.02.25
-0.56%
17.02.24

buy
Xpel Inc.

Start price
Target price
Perf. (%)
€46.20
03.02.24
-
03.02.25
1.30%
02.03.24

buy
Hammond Power Solutions Inc.

Start price
Target price
Perf. (%)
€67.50
03.02.24
-
03.02.25
18.52%
02.03.24

buy
Payfare Inc.

Start price
Target price
Perf. (%)
€5.00
03.02.24
-
03.02.25
-9.60%
02.03.24

buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.92
03.02.24
€1.00
03.02.25
20.87%
12.02.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Pharmaron Beijing Co. Ltd.

Start price
Target price
Perf. (%)
€0.99
03.02.24
€1.00
03.02.25
3.55%
17.02.24

Genovis Ab

Start price
Target price
Perf. (%)
€3.98
03.02.24
€2.00
03.02.25
2.89%
17.02.24

Wuxi Apptec Co. Ltd

Start price
Target price
Perf. (%)
€5.30
03.02.24
€2.00
03.02.25
-4.72%
17.02.24

Clearmind Medicine Inc.

Start price
Target price
Perf. (%)
€1.65
03.02.24
-
03.02.25
-34.18%
09.08.24

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Low dividend yield expected
Bad rating
buy
Cardiol Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.11
03.02.24
-
03.02.25
18.02%
17.02.24